|Positive WB detected in||U2OS cells, NIH/3T3 cells, MCF-7 cells|
|Western Blot (WB)||WB : 1:500-1:2000|
|Sample-dependent, check data in validation data gallery|
10934-1-AP targets Cyclin D2 in WB,ELISA applications and shows reactivity with human, mouse samples.
|Tested Reactivity||human, mouse|
|Cited Reactivity||goat, human, mouse, pig|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Cyclin D2 fusion protein Ag1377|
|Full Name||cyclin D2|
|Calculated molecular weight||32 kDa|
|Observed molecular weight||34 kDa|
|GenBank accession number||BC010958|
|Gene ID (NCBI)||894|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.|
CCND2 belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. CCND2 forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. CCND2 has been shown to interact with and be involved in the phosphorylation of tumor suppressor protein Rb. High level expression of CCND2 was observed in ovarian and testicular tumors.
Cancer Manag Res
ADAR1 may be involved in the proliferation of acute myeloid leukemia cells via regulation of the Wnt pathway.
Cancer Biol Med
Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis.
Cell Death Dis
GLI1 reduces drug sensitivity by regulating cell cycle through PI3K/AKT/GSK3/CDK pathway in acute myeloid leukemia.
Mol Med Rep
De novo CD5-positive diffuse large B-cell lymphomas show high specificity for cyclin D2 expression.
Int J Hematol
Inhibition of CDK4/6 and autophagy synergistically induces apoptosis in t(8;21) acute myeloid leukemia cells.